BMJ  2005;331:19 (2 July), doi:10.1136/bmj.38488.385995.8F (published 20 June 2005)

Paper

Fate of biomedical research protocols and publication bias in France: retrospective cohort study

Evelyne Decullier, research fellow1, Véronique Lhéritier, research assistant2, François Chapuis, senior researcher3

1 Clinical Research Unit, DIM des Hospices Civils de Lyon, 162 avenue Lacassagne, 69424 Lyon cedex 03, France, 2 CCPPRB Lyon B - Hôpital Hotel-Dieu, place de l'Hopital, 69002 Lyon, 3 French National Confederation of Research Ethics Committees - Hôpital Hotel-Dieu, 69002 Lyon

Correspondence to: F Chapuis francois.chapuis{at}chu-lyon.fr

Objectives To describe the fate of protocols approved by the French research ethics committees, a national system created by the French 1988 Huriet-Sérusclat Act; to assess publication bias at a national level.

Design Retrospective cohort study.

Setting Representative sample of 25/48 French research ethics committees in 1994.

Protocols 649 research protocols approved by committees, with follow-up information.

Main outcome measures Protocols' initial characteristics (design, study size, investigator) abstracted from committees' archives; follow-up information (rates of initiation, completion, and publication) obtained from mailed questionnaire to principal investigators.

Results Completed questionnaires were available for 649/976 (69%) protocols. Of these, 581 (90%) studies were initiated, 501/581 (86%) were completed, and 190/501 (38%) were published. Studies with confirmatory results were more likely to be published as scientific papers than were studies with inconclusive results (adjusted odds ratio 4.59, 95% confidence interval 2.21 to 9.54). Moreover, studies with confirmatory results were published more quickly than studies with inconclusive results (hazard ratio 2.48, 1.36 to 4.55).

Conclusion At a national level, too many research studies are not completed, and among those completed too many are not published. We suggest capitalising on research ethics committees to register and follow all authorised research on human participants on a systematic and prospective basis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Waiving confidentiality for the greater good
An-Wen Chan, Ross Upshur, Jerome A Singh, Davina Ghersi, François Chapuis, and Douglas G Altman
BMJ 2006 332: 1086-1089. [Full Text] [PDF]

Dissemination of results needs to be tracked as well as the funding is
James McCormack, Peter Loewen, and Peter Jewesson
BMJ 2005 331: 456. [Extract] [Full Text]

French ethics committees should tackle publication bias
BMJ 2005 331: 0. [Full Text]

Compulsory registration of clinical trials
Kamran Abbasi
BMJ 2004 329: 637-638. [Extract] [Full Text] [PDF]

Time to register randomised trials
Richard Horton and Richard Smith
BMJ 1999 319: 865-866. [Extract] [Full Text] [PDF]

Publication bias: evidence of delayed publication in a cohort study of clinical research projects
Jerome M Stern and R John Simes
BMJ 1997 315: 640-645. [Abstract] [Full Text]

This article has been cited by other articles:

  • Blumle, A, Antes, G, Schumacher, M, Just, H, von Elm, E (2008). Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others. J. Med. Ethics 34: e20-e20 [Abstract] [Full text]  
  • Arshad, A, Arkwright, P D (2008). Status of healthcare studies submitted to UK research ethics committees for approval in 2004-5. J. Med. Ethics 34: 393-395 [Abstract] [Full text]  
  • Decullier, E., Chapuis, F. (2007). Oral presentation bias: a retrospective cohort study. J. Epidemiol. Community Health 61: 190-193 [Abstract] [Full text]  
  • Chan, A.-W., Upshur, R., Singh, J. A, Ghersi, D., Chapuis, F., Altman, D. G (2006). Waiving confidentiality for the greater good.. BMJ 332: 1086-1089 [Full text]  
  • Delgado-Rodriguez, M. (2006). Systematic reviews of meta-analyses: applications and limitations. J. Epidemiol. Community Health 60: 90-92 [Full text]  
  • McCormack, J., Loewen, P., Jewesson, P. (2005). Dissemination of results needs to be tracked as well as the funding is. BMJ 331: 456-456 [Full text]  

Rapid Responses:

Read all Rapid Responses

Ethics committees must require trial registration
Andrew Jull
bmj.com, 4 Jul 2005 [Full text]
Publication bias, selective dissemination and trial registries
James P. McCormack, et al.
bmj.com, 15 Jul 2005 [Full text]



Doc2Doc Vacancy
Access jobs at BMJ Careers
Whats new online at Student 

BMJ